Clinical Trial Update: Helping People Adhere to Their Varenicline Treatment by Co-creating a Conversational Agent: A Feasibility Study [NA]

View source ↗

Summary

A completed feasibility study evaluating a conversational agent to support adherence to varenicline for smoking cessation, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Drugs mentioned

• Varenicline (varenicline)

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Medication Adherence, Smoking Cessation | NA | Status: COMPLETED | Results posted: 2026-03-31